{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:46:39Z","timestamp":1791452799167,"version":"4.3.3"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Golden Casket Clinical Fellowship"},{"name":"Perrigo Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>STUDY QUESTION<\/jats:title><jats:p>In women with threatened miscarriage, does progesterone supplementation until the completion of the first trimester of pregnancy increase the probability of live birth?<\/jats:p><\/jats:sec><jats:sec><jats:title>SUMMARY ANSWER<\/jats:title><jats:p>In women with threatened miscarriage, 400\u2009mg vaginal progesterone nightly, from onset of bleeding until 12\u2009weeks, did not increase live birth rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>WHAT IS KNOWN ALREADY<\/jats:title><jats:p>Limited evidence has indicated that vaginal micronized progesterone may make little or no difference to the live birth rate when compared with placebo in women with threatened miscarriage. Subgroup analysis of one recent randomized trial reported that in women with bleeding and at least one previous miscarriage, progesterone might be of benefit.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title><jats:p>We performed a randomized, double-blinded, placebo-controlled trial between February 2012 and April 2019. Eligible pregnant women under 10\u2009weeks gestation, experiencing a threatened miscarriage as apparent from vaginal bleeding were randomized into two groups in a 1:1 ratio: the intervention group received 400\u2009mg progesterone as vaginal pessaries, the control group received placebo vaginal pessaries, both until 12\u2009weeks gestation. The primary endpoint was live birth. We planned to randomize 386 women (193 per group). The study was stopped at a planned interim analysis for futility after randomization of 278 women.<\/jats:p><\/jats:sec><jats:sec><jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title><jats:p>This trial was conducted at the Mater Mothers\u2019 Hospital, a tertiary centre for maternity care in South Brisbane, Queensland, Australia. We randomized 139 women to the intervention group and 139 women to the placebo group. Primary outcome data were available for 136 women in the intervention group and 133 women in the placebo group.<\/jats:p><\/jats:sec><jats:sec><jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title><jats:p>The live birth rates were 82.4% (112\/136) and 84.2% (112\/133) in the intervention group and placebo group, respectively (risk ratio (RR) 0.98, 95% CI 0.88 to 1.09; risk difference \u22120.02, 95% CI \u22120.11 to 0.07; P\u2009=\u20090.683). Among women with at least one previous miscarriage, live birth rates were 80.6% (54\/67) and 84.4% (65\/77) (RR 0.95, 95% CI 0.82\u20131.11; P\u2009=\u20090.550). No significant effect was seen from progesterone in women with two (RR 1.28, 95% CI 0.96\u20131.72; P\u2009=\u20090.096) or more (RR 0.79, 95% CI 0.53\u20131.19; P\u2009=\u20090.267) previous miscarriages. Preterm birth rates were 12.9% and 9.3%, respectively (RR 1.38; 95% CI 0.69 to 2.78; P\u2009=\u20090.361). Median birth weight was 3310 vs 3300 g (P\u2009=\u20090.992). There were also no other significant differences in obstetric and perinatal outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title><jats:p>Our study was single centre and did not reach the planned sample size because it was stopped prematurely at an interim analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title><jats:p>We did not find evidence supporting the treatment effect of vaginal progesterone in women with threatened miscarriage. Progesterone in this setting should not be routinely used for threatened miscarriage. The treatment effect in women with threatened miscarriage after previous miscarriages warrants further research.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title><jats:p>Mothers\u2019 and babies Golden Casket Clinical Fellowship (L.A.M.). Progesterone and placebo pessaries were provided by Perrigo Australia.<\/jats:p><jats:p>B.W.J.M. reports grants from NHMRC, personal fees from ObsEva, personal fees from Merck KGaA, personal fees from Guerbet, personal fees from iGenomix, outside the submitted work.<\/jats:p><\/jats:sec><jats:sec><jats:title>TRIAL REGISTRATION NUMBER<\/jats:title><jats:p>ACTRN12611000405910<\/jats:p><\/jats:sec><jats:sec><jats:title>TRIAL REGISTRATION DATE<\/jats:title><jats:p>19 April 2011<\/jats:p><\/jats:sec><jats:sec><jats:title>DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title><jats:p>06 February 2012<\/jats:p><\/jats:sec>","DOI":"10.1093\/humrep\/dead029","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T15:19:22Z","timestamp":1676906362000},"page":"560-568","source":"Crossref","is-referenced-by-count":34,"title":["Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2044-8681","authenticated-orcid":false,"given":"Lucas A","family":"McLindon","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"},{"name":"Department of Obstetrics and Gynaecology, University of Queensland , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-4491","authenticated-orcid":false,"given":"Gabriel","family":"James","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"},{"name":"Department of Obstetrics and Gynaecology, University of Queensland , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7319-6938","authenticated-orcid":false,"given":"Michael M","family":"Beckmann","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"},{"name":"Department of Obstetrics and Gynaecology, University of Queensland , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bertolone","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-8091","authenticated-orcid":false,"given":"Kassam","family":"Mahomed","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Queensland , Brisbane, Queensland, Australia"},{"name":"Department of Obstetrics and Gynaecology, Ipswich Hospital , Ipswich, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vane","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Gleed","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Grey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Tettamanzi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Mater Mothers\u2019 Hospitals, Mater Health , Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-550X","authenticated-orcid":false,"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre , Clayton, Victoria, Australia"},{"name":"Aberdeen Centre for Women\u2019s Health Research, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen , Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-0909","authenticated-orcid":false,"given":"Wentao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre , Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1037\/1040-3590.10.2.176","article-title":"Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample","volume":"10","author":"Antony","year":"1998","journal-title":"Psychol Assess"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1472-6483(10)60300-8","article-title":"Early risk factors for miscarriage: a prospective cohort study in pregnant women","volume":"17","author":"Arck","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","article-title":"Maternal progestin intake and risk of hypospadias","volume":"159","author":"Carmichael","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/humrep\/deaa327","article-title":"Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial","volume":"36","author":"Chan","year":"2021","journal-title":"Hum Reprod"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(21)01379-9","article-title":"Making miscarriage matter","volume":"398","author":"Chong","year":"2021","journal-title":"Lancet"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa1813730","article-title":"A randomized trial of progesterone in women with bleeding in early pregnancy","volume":"380","author":"Coomarasamy","year":"2019","journal-title":"N Engl J Med"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/01443615.2010.489164","article-title":"Fetal loss in threatened abortion after demonstration of fetal cardiac activity in a low socioeconomic population","volume":"30","author":"Dede","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"2023040319422246200_","first-page":"Cd013792","article-title":"Progestogens for preventing miscarriage: a network meta-analysis","volume":"4","author":"Devall","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00404-010-1367-7","article-title":"Predictive power progesterone combined with beta human chorionic gonadotropin measurements in the outcome of threatened miscarriage","volume":"283","author":"Duan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.maturitas.2009.11.013","article-title":"Dydrogesterone support in threatened miscarriage","volume":"65(Suppl 1)","author":"El-Zibdeh","year":"2009","journal-title":"Maturitas"},{"key":"2023040319422246200_","first-page":"26","article-title":"Double-blind controlled trial of progesterone substitution in threatened abortion","volume":"8","author":"Gerhard","year":"1987","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"2023040319422246200_","first-page":"CD003511","article-title":"Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology","volume":"2019","author":"Haas","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2023040319422246200_","first-page":"CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/AOG.0b013e3181b79796","article-title":"Association between first-trimester vaginal bleeding and miscarriage","volume":"114","author":"Hasan","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/14767058.2017.1286315","article-title":"Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial","volume":"31","author":"Ismail","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/GCO.0b013e3283404e44","article-title":"Obstetric outcome after early placental complications","volume":"22","author":"Jauniaux","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","article-title":"The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories","volume":"33","author":"Lovibond","year":"1995","journal-title":"Behav Res Ther"},{"key":"2023040319422246200_","first-page":"e1","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1196\/annals.1335.022","article-title":"Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy","volume":"1034","author":"Palagiano","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.maturitas.2009.11.016","article-title":"Dydrogesterone in threatened miscarriage: a Malaysian experience","volume":"65(Suppl 1)","author":"Pandian","year":"2009","journal-title":"Maturitas"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/09513590701254030","article-title":"The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion","volume":"23","author":"Salazar","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2023040319422246200_","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2009.02427.x","article-title":"Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review","volume":"117","author":"Saraswat","year":"2010","journal-title":"BJOG"},{"key":"2023040319422246200_","first-page":"94","article-title":"Psychological sequelae of miscarriage: a controlled study using the general health questionnaire and the hospital anxiety and depression scale","volume":"42","author":"Thapar","year":"1992","journal-title":"Br J Gen Pract"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/4\/560\/49734530\/dead029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/4\/560\/49734530\/dead029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T23:16:30Z","timestamp":1701904590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/4\/560\/7048705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2,20]]},"published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead029","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,2,20]]}}}